Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 24, 2011


Bruce Taillon, formerly the director of healthcare business development at Roche's 454 Life Sciences division, is now the head of global technology business development at Enzo Life Science. While at 454, Taillon helped develop the company's next-generation sequencing platforms, including for its potential use in diagnostic assays. He also has experience leading R&D teams in the areas of genomics, proteomics, and drug development.

Pathogenica founder and CEO Yemi Adesokan has been named by MIT's Technology Review as one of its top innovators under the age of 35, for his work on developing sequencing-based diagnostic tests that can identify pathogens. His company is aiming to launch an FDA-approved test to diagnose HPV by 2012, and is also working on tests that can monitor drug resistance in HIV patients (CSN 8/17/2011). Previously, Adesokan was a research fellow in genetics at Harvard Medical School. He holds a PhD in chemistry from the University of California, Irvine.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.